Seoul ST. Mary's hospital — Seoul

Public research footprint of Seoul ST. Mary's hospital, compiled from the ClinicalTrials.gov public registry.

813

Registered studies

238

Active

126

Recruiting now

381

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Diabetes (Insulin-requiring, Type 1 or Type 2) · Resectable Non-Small-Cell Lung Cancer · Relapsed or Refractory Multiple Myeloma (RRMM)

Recently updated registry entries

NCT07220759 — Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following… (Active Not Recruiting)
NCT07742735 — A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in… (Recruiting)
NCT06016842 — A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Seoul ST. Mary's hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.